Examiner: GHALI, ISIS A D

Tech Center 1600 • Art Units: 1611

This examiner grants 28% of resolved cases

Performance Statistics

27.9%

Allow Rate

-32.1% vs TC avg

902

Total Applications

+41.5%

Interview Lift

1599

Avg Prosecution Days

Based on 845 resolved cases, 2023–2026

1.1%

§101 Eligibility

7.4%

§102 Novelty

51.2%

§103 Obviousness

24.9%

§112 Clarity

App #	Title	Status	Assignee
17503762	MULTI-PHASE ORAL COMPOSITION FOR DELIVERING ORAL CARE ACTIVE AGENTS	Non-Final OA	The Procter & Gamble Company
18909563	DERMAL PATCH AND SYSTEMS, KITS, AND METHODS ASSOCIATED THEREWITH	Final Rejection	Covidien LP
19213573	TRANSDERMAL DELIVERY PATCH FOR TREATING PAIN	Final Rejection	Teikoku Pharma USA, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.